Categories for... News

News

Sygnature Discovery partners the Oncology Development Programme (ODP2) to find UK-based breakthroughs in Oncology

READ ARTICLE

News

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’

READ ARTICLE

News

Sygnature Discovery acquires Peak Proteins

READ ARTICLE

News

500 – and counting!

READ ARTICLE

News

Taking a 3D view of heart failure with River BioMedics

READ ARTICLE

News

Our new Chairman: Dr Charles Woler

READ ARTICLE

News

Sygnature strengthens with MedChemica software solution

READ ARTICLE

News

Expansions, transactions and all action: Our 2021 recap!

READ ARTICLE

News

New CFO Jordison steps up

READ ARTICLE

News

Sygnature and Epigeneron, the Japanese Bio-Venture, Join Forces in Collaboration

READ ARTICLE

Drug Discovery News

Five Arrows invests in Sygnature Discovery

READ ARTICLE

Drug Discovery News

Sygnature Discovery’s Early CMC Development Expansion: Unveiling New Opportunities

READ ARTICLE